Cargando…
A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus
Anti-adrenergic therapy has been widely accepted as an important therapeutic intervention in patients with chronic heart failure. However, there has been continuing controversy regarding the risks and clinical significance of metabolic effects of different anti-adrenergic drugs. This review summariz...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291308/ https://www.ncbi.nlm.nih.gov/pubmed/18078015 |
| _version_ | 1782152441896108032 |
|---|---|
| author | Wilson Tang, WH |
| author_facet | Wilson Tang, WH |
| author_sort | Wilson Tang, WH |
| collection | PubMed |
| description | Anti-adrenergic therapy has been widely accepted as an important therapeutic intervention in patients with chronic heart failure. However, there has been continuing controversy regarding the risks and clinical significance of metabolic effects of different anti-adrenergic drugs. This review summarizes what has been learned from clinical trial evidence regarding the benefits of anti-adrenergic drugs in diabetic patients with chronic heart failure. |
| format | Text |
| id | pubmed-2291308 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-22913082008-04-22 A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus Wilson Tang, WH Vasc Health Risk Manag Review Anti-adrenergic therapy has been widely accepted as an important therapeutic intervention in patients with chronic heart failure. However, there has been continuing controversy regarding the risks and clinical significance of metabolic effects of different anti-adrenergic drugs. This review summarizes what has been learned from clinical trial evidence regarding the benefits of anti-adrenergic drugs in diabetic patients with chronic heart failure. Dove Medical Press 2007-10 /pmc/articles/PMC2291308/ /pubmed/18078015 Text en © 2006 Dove Medical Press Limited. All rights reserved |
| spellingShingle | Review Wilson Tang, WH A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus |
| title | A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus |
| title_full | A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus |
| title_fullStr | A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus |
| title_full_unstemmed | A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus |
| title_short | A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus |
| title_sort | critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus |
| topic | Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291308/ https://www.ncbi.nlm.nih.gov/pubmed/18078015 |
| work_keys_str_mv | AT wilsontangwh acriticalreviewofantiadrenergictherapyinpatientswithheartfailureanddiabetesmellitus AT wilsontangwh criticalreviewofantiadrenergictherapyinpatientswithheartfailureanddiabetesmellitus |